PRECISION BIOSCIENCES INC - Common Stock, par value $0.000005 per share (DTIL)

Historical Holders from Q1 2024 to Q4 2025

Symbol
DTIL on Nasdaq
Type / Class
Equity / Common Stock, par value $0.000005 per share
Shares outstanding
11,847,682
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
4,649,562
Holdings value
$25,664,758
% of all portfolios
0%
Number of holders
54
Number of buys
25
Number of sells
17
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of PRECISION BIOSCIENCES INC - Common Stock, par value $0.000005 per share (DTIL) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Readout Capital, LP 9.4% +5.6% $4,980,934 +$829,645 1,119,311 +20% Matthew Smith 30 Jun 2025
Bleichroeder LP 9.7% $4,783,750 1,075,000 Bleichroeder LP 30 Jun 2025
Lynx1 Capital Management LP 8.8% -12% $5,755,026 +$1,526,501 1,042,596 +36% LYNX1 CAPITAL MANAGEMENT LP 30 Sep 2025
TANG CAPITAL MANAGEMENT LLC 6.4% $3,588,860 673,332 TANG CAPITAL MANAGEMENT, LLC 31 Mar 2025
NOVARTIS PHARMA AG 3.7% -34% $1,840,435 413,581 0% Novartis Pharma AG 30 Jun 2025
HIGHBRIDGE CAPITAL MANAGEMENT LLC 3.7% $2,165,312 406,250 Highbridge Capital Management, LLC 31 Mar 2025
Weinstein Benjamin 5.2% $2,107,956 395,489 Weinstein Benjamin 18 Mar 2025
As of 30 Sep 2025 PRECISION BIOSCIENCES INC - Common Stock, par value $0.000005 per share (DTIL) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 4,649,562 shares of 11,847,682 outstanding shares and own 39% of the company stock as of 30 Sep 2025.

Top 25 institutional shareholders of PRECISION BIOSCIENCES INC - Common Stock, par value $0.000005 per share (DTIL) own 39% of the company based on 13F filings as of 30 Sep 2025

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
Bleichroeder LP 9.1% 1,075,000 0% 1.2% $5,934,000
Lynx1 Capital Management LP 8.8% 1,042,596 +0.63% 1.2% $5,755,130
TANG CAPITAL MANAGEMENT LLC 5.5% 653,649 0% 0.14% $3,608,142
VANGUARD GROUP INC 4.2% 492,596 +22% 0% $2,719,130
RENAISSANCE TECHNOLOGIES LLC 1.7% 196,177 +144% 0% $1,082,897
BOOTHBAY FUND MANAGEMENT, LLC 1.5% 178,535 -11% 0.02% $985,513
ACADIAN ASSET MANAGEMENT LLC 1% 119,359 -47% 0% $658,000
GEODE CAPITAL MANAGEMENT, LLC 0.92% 109,521 +41% 0% $604,598
BlackRock, Inc. 0.83% 98,699 +72% 0% $544,819
TWO SIGMA INVESTMENTS, LP 0.7% 83,092 +408% 0% $458,668
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.52% 61,901 0% 0.01% $341,694
Quarry LP 0.5% 59,375 0% 0.08% $327,750
Tejara Capital Ltd 0.5% 58,752 -0.17% 0.18% $324,311
COMMONWEALTH EQUITY SERVICES, LLC 0.47% 55,845 +4.6% 0% $308,000
TWO SIGMA ADVISERS, LP 0.44% 52,024 0% $287,172
DIMENSIONAL FUND ADVISORS LP 0.37% 43,641 -19% 0% $240,898
STATE STREET CORP 0.32% 38,142 +45% 0% $210,544
NORTHERN TRUST CORP 0.32% 38,067 -5.6% 0% $210,130
UBS Group AG 0.21% 24,476 -53% 0% $135,107
CITADEL ADVISORS LLC 0.19% 22,142 0% $122,224
Velan Capital Investment Management LP 0.17% 20,000 0.1% $110,400
GSA CAPITAL PARTNERS LLP 0.15% 17,722 0.01% $98,000
Virtu Financial LLC 0.13% 15,166 0% $84,000
Quadrature Capital Ltd 0.12% 13,971 0% $77,120
Vanguard Personalized Indexing Management, LLC 0.11% 13,127 0% $72,461

Institutional Holders of PRECISION BIOSCIENCES INC - Common Stock, par value $0.000005 per share (DTIL) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 8 $33 $4.12 1
2025 Q3 4,649,562 $25,664,758 +$1,234,800 $5.52 54
2025 Q2 4,437,938 $18,638,020 +$2,152,791 $4.20 51
2025 Q1 3,786,321 $18,062,451 +$340,769 $4.77 47
2024 Q4 3,859,340 $14,708,103 -$4,075,765 $3.81 51
2024 Q3 3,323,629 $29,812,914 +$1,425,206 $8.96 50
2024 Q2 3,161,323 $30,774,875 -$108,215 $9.73 45
2024 Q1 3,155,622 $42,757,614 +$42,755,553 $13.56 40